Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.

Kerstin MichalskiJuri RufChristian GoetzAnna Katharina SeitzAndreas K BuckConstantin LapaPhilipp E Hartrampf

Published in: European journal of nuclear medicine and molecular imaging (2020)

FDG+/PSMA- lesions are a negative predictor of overall survival in patients with mCRPC undergoing RLT. However, it remains to be determined if patients with FDG+/PSMA- lesions should be excluded from PSMA RLT.

Keyphrases

pet ct
positron emission tomography
patients undergoing
pet imaging
stem cells
computed tomography